SOUTHERN AFRICAN ACADEMY OF PHARMACY CIC

Company limited by guarantee

Company Registration Number:
13760381 (England and Wales)

Unaudited statutory accounts for the year ended 30 November 2023

Period of accounts

Start date: 1 December 2022

End date: 30 November 2023

SOUTHERN AFRICAN ACADEMY OF PHARMACY CIC

Contents of the Financial Statements

for the Period Ended 30 November 2023

Balance sheet
Additional notes
Balance sheet notes
Community Interest Report

SOUTHERN AFRICAN ACADEMY OF PHARMACY CIC

Balance sheet

As at 30 November 2023

Notes 2023 2022


£

£
Current assets
Stocks:   0
Debtors: 3 5
Cash at bank and in hand: 373 50
Investments:   0
Total current assets: 373 55
Net current assets (liabilities): 373 55
Total assets less current liabilities: 373 55
Provision for liabilities: ( 200 )
Total net assets (liabilities): 173 55
Members' funds
Profit and loss account: 173 55
Total members' funds: 173 55

The notes form part of these financial statements

SOUTHERN AFRICAN ACADEMY OF PHARMACY CIC

Balance sheet statements

For the year ending 30 November 2023 the company was entitled to exemption under section 477 of the Companies Act 2006 relating to small companies.

The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

These accounts have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The directors have chosen not to file a copy of the company's profit and loss account.

This report was approved by the board of directors on 30 August 2024
and signed on behalf of the board by:

Name: Thomas Thomik
Status: Director

The notes form part of these financial statements

SOUTHERN AFRICAN ACADEMY OF PHARMACY CIC

Notes to the Financial Statements

for the Period Ended 30 November 2023

  • 1. Accounting policies

    Basis of measurement and preparation

    These financial statements have been prepared in accordance with the provisions of Financial Reporting Standard 101

SOUTHERN AFRICAN ACADEMY OF PHARMACY CIC

Notes to the Financial Statements

for the Period Ended 30 November 2023

  • 2. Employees

    2023 2022
    Average number of employees during the period 2 2

SOUTHERN AFRICAN ACADEMY OF PHARMACY CIC

Notes to the Financial Statements

for the Period Ended 30 November 2023

3. Debtors

2023 2022
£ £
Other debtors 5
Total   5

COMMUNITY INTEREST ANNUAL REPORT

SOUTHERN AFRICAN ACADEMY OF PHARMACY CIC

Company Number: 13760381 (England and Wales)

Year Ending: 30 November 2023

Company activities and impact

The company is a professional association of pharmacists who are based in or have links to Southern Africa. The membership is comprised of individuals based mainly in Southern Africa and the UK, but also other parts of the world. The company provides a platform for discussion and sharing of knowledge related to healthcare issues. The company activities have benefitted the community in the following ways;- members have benefited from continuing professional development (CPD) sessions that have been organised by the company.- members have been able to share knowledge on and discuss professional matters via the company's social media platforms.- members have been able to gain access to educational opportunities and invites to forums/conferences as a result of the company's activities

Consultation with stakeholders

The company's stakeholders are the membership. The company's executive is charged with the day to day running of the company.Members are asked for their input on what activities could be of benefit to them. This is done via surveys, question and answer sessions in meetings, and direct conversation.The interaction with membership has enabled the company to give members access to Continuing Professional Development sessions and support institutions/organisations identified by membership.

Directors' remuneration

No remuneration was received

Transfer of assets

No transfer of assets other than for full consideration

This report was approved by the board of directors on
30 August 2024

And signed on behalf of the board by:
Name: Thomas Thomik
Status: Director